Peter F. Lang
Director of Finance/CFO bij OPTHEA LIMITED
Profiel
Peter F.
Lang is currently the Chief Financial Officer at Opthea Ltd.
He was previously a Managing Director & Partner at Ridge Advisory LLC and the Chief Financial Officer at Aerie Pharmaceuticals, Inc. for a brief period in 2022.
Lang holds an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Actieve functies van Peter F. Lang
Bedrijven | Functie | Begin |
---|---|---|
OPTHEA LIMITED | Director of Finance/CFO | 27-10-2023 |
Eerdere bekende functies van Peter F. Lang
Bedrijven | Functie | Einde |
---|---|---|
AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | 21-11-2022 |
Ridge Advisory LLC | Corporate Officer/Principal | - |
Opleiding van Peter F. Lang
The University of Chicago Booth School of Business | Masters Business Admin |
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OPTHEA LIMITED | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Ridge Advisory LLC |